JIPMER calls For Proposals To Scientific Advisory Committee June 2024, Details

Published On 2024-05-22 09:45 GMT   |   Update On 2024-05-22 09:45 GMT

Puducherry- Through a circular, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry has informed about the submission of the proposal in the 7th JIPMER Scientific Advisory Committee Meeting (JSAC) in June 2024. The last date for submission of proposals (by mail and hard copy) is May 25, 2024.

On 13th June 2024, IPMER is going to organise the 3rd meeting of the JIPMER Scientific Advisory Committee (JSAC).

Advertisement

Candidates are instructed to use the combined format containing Section-1 (for JSAC), and Section-2 (for Intramural Research Fund Committee) and fill both the sections accordingly. The Format is available under the Research Category on the official website of JIPMER, which is mentioned in the notice.

The participants should ensure that they submit both an original hard copy and a Xerox copy of the research proposal, along with a cover letter addressed to the Dean (Research). The hard copy should be written in 11 font size, with 1.5 spacing and page numbering, using both sides of A4 size paper. If participants fail to submit the research proposal in the given format the proposal will not be accepted and no subsequent modification of the proposals will also not be accepted. However, only citing and listing references as per the International Committee of Medical Journal Editors (ICMJE) style will be accepted.

Candidates are required to mail the soft copy of the proposal in PDF format and the General Information of Part-A of the Proposal in a Word file document to the official Gmail ID of JIPMER with the subject of the mail as “Submission of proposal for the 7th JSAC meeting in June 2024”.

The notice further stated that “There can be only one co-investigator from the same department to discourage gift co-investigatorship. It applies to both the department of primary investigator and the department of collaborating investigator”.

To view the circular, click the link below

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News